Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy.

Literature DB >> 20457195

EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy.

Hiroshi Maeda¹, Yasuhiro Matsumura.

Abstract

Entities: Disease

Mesh：

Substances：
Antineoplastic Agents

Year: 2010 PMID： 20457195 DOI： 10.1016/j.addr.2010.05.001

Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN： 0169-409X Impact factor: 15.470

Keyword Cloud
Cited

× No keyword cloud information.

56 in total

Review 1. Treating metastatic cancer with nanotechnology.

Authors: Avi Schroeder; Daniel A Heller; Monte M Winslow; James E Dahlman; George W Pratt; Robert Langer; Tyler Jacks; Daniel G Anderson
Journal: Nat Rev Cancer Date: 2011-12-23 Impact factor: 60.716

2. Antitumor activity and molecular dynamics simulations of paclitaxel-laden triazine dendrimers.

Authors: Jongdoo Lim; Su-Tang Lo; Sonia Hill; Giovanni M Pavan; Xiankai Sun; Eric E Simanek
Journal: Mol Pharm Date: 2012-02-03 Impact factor: 4.939

Review 3. Intraoperative fluorescence imaging in thoracic surgery.

Authors: Andrew D Newton; Jarrod D Predina; Shuming Nie; Philip S Low; Sunil Singhal
Journal: J Surg Oncol Date: 2018-08-11 Impact factor: 3.454

4. Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment.

Authors: Alina Sesarman; Lucia Tefas; Bianca Sylvester; Emilia Licarete; Valentin Rauca; Lavinia Luput; Laura Patras; Sebastian Porav; Manuela Banciu; Alina Porfire
Journal: Drug Deliv Transl Res Date: 2019-02 Impact factor: 4.617

5. Leukemia Inhibitory Factor-Loaded Nanoparticles with Enhanced Cytokine Metabolic Stability and Anti-Inflammatory Activity.

Authors: Stephanie M Davis; Derek Reichel; Younsoo Bae; Keith R Pennypacker
Journal: Pharm Res Date: 2018-01-02 Impact factor: 4.200

10. Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.

Authors: Kenji Yokoi; Biana Godin; Carol J Oborn; Jenolyn F Alexander; Xuewu Liu; Isaiah J Fidler; Mauro Ferrari
Journal: Cancer Lett Date: 2012-09-18 Impact factor: 8.679

EPR effect based drug design and clinical outlook for enhanced cancer chemotherapy.

Review 1. Treating metastatic cancer with nanotechnology.

2. Antitumor activity and molecular dynamics simulations of paclitaxel-laden triazine dendrimers.

Review 3. Intraoperative fluorescence imaging in thoracic surgery.

4. Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment.

5. Leukemia Inhibitory Factor-Loaded Nanoparticles with Enhanced Cytokine Metabolic Stability and Anti-Inflammatory Activity.

Review 6. Image-guided nanosystems for targeted delivery in cancer therapy.

7. Discoidal Porous Silicon Particles: Fabrication and Biodistribution in Breast Cancer Bearing Mice.

8. Porphyrin-phospholipid liposomes with tunable leakiness.

9. Markedly enhanced permeability and retention effects induced by photo-immunotherapy of tumors.

10. Porous silicon nanocarriers for dual targeting tumor associated endothelial cells and macrophages in stroma of orthotopic human pancreatic cancers.